In 1976 Ebringer and his colleagues reported at a meeting under the auspices of INSERM that, as a result of a prospective search, they had found that Klebsiella aerogenes (a species of a genus in the tribe Klebsielleae of the Enterobacteriacae) shared antigens with HLA B27 lymphocytes when tested with rabbit antisera (Ebringer et al., 1976) . The same group subsequently reported a cross-reactivity with Enterobacter aerogenes, a different genus in the same tribe, and Yersinia enterocolitica, another member of the Enterobacteriacae (Ebringer et al., 1977) .
No detailed description of the experiments establishing the serological cross-reactions has to our knowledge been published or referred to in the extensive comment this abstract excited. Klebsiella pneumoniae (Edwards and Ewing, 1972) has been described in further work as the Klebsiella species responsible (Ebringer et al., 1978) . This apparent variation in the implicated species is in fact illusory and due to the differences in British and American nomenclature. The USA species Klebsiella pneumoniae (Edwards and Ewing, 1972) includes a wide variety of species biochemically subdivided in the UK into K. aerogenes, K. pneumoniae (sensu strictu), K. edwardsii, and K. atlantae (Cowan and Steel, 1965) and serologically contains some 75 capsular serotypes. A majority of the K. pneumoniae strains (Edwards and Ewing, 1972) implicated by Ebringer et al. (1977) appear to be K. aerogenes. Klebsiella species are common agents in infections acquired in hospitals in the UK. For example, they are the second commonest cause of confirmed Gramnegative bacteraemia after Escherichia coli (Communicable Disease Report, 1977) . Klebsiella spp. have been isolated from up to 30 % ofstools examined in those just admitted to hospital and those who are inpatients for some time (Casewell and Phillips, 1978a; Datta, 1969; Selden et al., 1971 ). Ebringer and his colleagues have recently claimed that carriage of K. pneumoniae (Edwards and Ewing, 1972) or Enterobacter aerogenes in the gut precedes a change in symptoms in patients with B27 (Ebringer et al., 1978) .
Biochemical bacterial taxonomy may not be the best way of describing how man in immunological terms sees his commensal flora. Antigenic crossreactions are common between bacteria in closely related genera, but their systematic study has not been pursued except as an explanation of observations made in the course of development of serotyping methods.
No antigenic cross-reaction has to our knowledge been reported between Klebsiella, Enterobacter, and strains of Salmonella, Shigella, Yersinia, or Chlamydia isolated from patients with HLA B27 who have developed peripheral arthritis after infection with such strains. However, many serological crossreactivities are known between these genera, Escherichia coli, and Brucella-another species which has been reported as a provocative factor for spondylitis in persons with HLA B27 (Hodinka et al., 1978) .
Yersinia pseudotuberculosis 0 serotypes crossreact with Salmonella 0 serotypes because they share common 3-6 dideoxyhexose epitopes (Davies, 1958 (Davies, , 1961 . Enterobacter cloacae and Escherichia coli serotypes 017 and 077 cross-react with Y. pseudotuberculosis serotype IVA (Knapp, 1968) . Yersinia pseudotuberculosis is not known to provoke reactive arthritis more commonly in individuals with HLA B27, though a small number of cases have been recorded (Ahvonen, 1972; Chambers et al., 1978) .
Yersinia enterocolitica serotype 9 is known to cross-react with Vibrio cholerae (Barua and Watanabe, 1972) , and 0 antigenic relationships between Salmonella, V. cholerae, and Escherichia coli are described (Winkle et al., 1972) . Yersinia enterocolitica serotype 012 cross-reacts with Salmonella 0 antigen 047 (Wauters et al., 1971) . Yersinia enterocolitica serotype 9 cross-reacts with Brucella abortus, B. melitensis, and B. suis (Hurvell et al., 1971) . B. abortus cross-reactswith Vibro cholerae (Feeley, 1969) .
Many 0 antigenic cross-reactions of Escherichia and Shigella spp. have been described, including a cross-reaction between Sh. flexneri types 4b and 5, and, respectively, E. coil 055 and 0129 (Edwards and Ewing, 1972) .
At least 16 cross-reactivities between E. coli and Salmonella 0 antigens have been described (Orskov et al., 1977) ; and a further group of 4 cross-reactions between E. coil serotypes and K. pneumoniae (Edwards and Ewing, 1972) 0 types are described (Kaufman, 1949; Orskov, 1954 (Henriksen, 1954 ). An additional antigen, the common enterobacterial antigen of Kunin, is present, even if not expressed in immunogenic form, in many Enterobacteriacae, including Salmonella typhimurium and Yersinia enterocolitica serotypes 3 and 9 (Maeland and Digranes, 1975) .
The above brief survey indicates some of the very complex antigenic relationships, even within well defined species and classification serotypes, of the genera under discussion as provocative agents in individuals with HLA B27. Clearly another antigen not used in these serotyping schemes might actually be the hypothetical common antigen.
The potential importance of the reported association of prior carriage of Klebsiella pneumoniae (Edwards and Ewing, 1972) or Enterobacter aerogenes with subsequent change in symptoms, in patients with B27, encouraged us to conduct a further comparable study of patients with active and inactive AS using patients with RA as controls. A number of faeces submitted to a clinical microbiology laboratory for other reasons were also examined as a control on the bacteriological procedures used to isolate klebsiella, since no standard method for this has to our knowledge been published. patients with ankylosing spondylitis (AS) and 92 with rheumatoid arthritis (RA) were reassessed by one observer (DAB). All were outpatients attending the Rheumatology Department, Westminster Hospital, and had not been inpatients in the past year. They fulfilled the New York criteria for AS and the ARA criteria for definite RA, and in no case was the diagnosis in doubt. Patients with psoriasis, chronic inflammatory bowel disease, or Reiter's disease, non-Caucasians and all first generation immigrants of any race, were excluded. Those AS and RA patients included in the study were seen in approximately equal numbers throughout fortnightly periods of the study.
Each patient was clinically assessed as having quiescent disease requiring no anti-inflammatory drugs, or apparently active disease that was well controlled by drugs, or clearly active inflammatory disease of spine, peripheral joints, or eyes.
On clinical grounds the activity of disease in the spine or peripheral joints was recorded as mild, moderate or severe. Acute episodes of inflammatory disease of spine, peripheral joints or eyes in the preceding 2 months were recorded. Also noted were the date of the last hospital attendance, the last consumption of hospital food or drink, all drug therapy (including antibiotics) within the past year, and a history of hydrotherapy. The patient was asked if his rheumatic or eye symptoms had ever been clearly better or worse following an infection such as a cold, bronchitis, diarrhoea, abdominal upset, or urinary infection, or during the 6 weeks following such an infection. It was noted if the patient had a history of uveitis or peripheral arthritis in the case of AS, or possession of serum rheumatoid factor or erosive changes if classified as RA. The patient was asked to post to one of us (REW) a specimen of the next stool passed, the stool being identifiable only by a number, whose clinical correlates were not disclosed until all cultures had been concluded. A questionnaire was explained to the patient (Table 1) , (28) 37 (13) 20 (18) 17 (6) 36 (32) 23 (8) 9 (8) 17 (6) 4 (4) 6 (2) 8 (7) 3 (1) 2 (2) 6 (2) 2 (2) 0 (0) was comparable throughout the period of the study, rising from 12% (5 out of 42) in the first month to a constant 34 % (45 out of 129) thereafter. Since patients were seen with active and inactive AS and RA and included in assessment at an equal rate throughout the study period, this change, which might reflect an undetected methodological variation or a seasonal change in carriage rate, does not affect the interpretation of results.
As tables 4 and 5 show, there was no correlation between the initial clinical assessment category and klebsiella carriage. Seventy patients with AS and 51 patients with RA reported no significant differences in pain due to their arthritis over the 2-month period.
As Tables 6 and 7 show, there was no significant correlation between worsening of symptoms over a 2-month period and klebsiella carriage at initial assessment. 8*3% of AS patients initially carrying klebsiella complained of worsening of symptoms compared with 10-8% of those not carrying klebsiella. 27% of RA patients initially carrying klebsiella complained of worsening of symptoms compared with 23% of those not carrying klebsiella. All three spondylitic patients with initial positive klebsiella cultures who commented on symptom change (2 worsening and 1 improvement) had active spinal disease. Of those patients with negative klebsiella cultures and symptom improvement, 2 had inactive, 2 well controlled, and 3 active spinal disease, and 1 had active spinal and peripheral arthritis. Of those with negative klebsiella cultures and symptom worsening, 1 had inactive, 2 well controlled, and 2 active spinal disease, and 2 had both active spinal disease and peripheral arthritis. Assessing over a 4 month period (that is, 2 months before assessment and 2 months after assessment), klebsiella was present at initial assessment in 11 out of 48 of those who had either active disease of spine or peripheral joints, or a recent exacerbation ofspine, joint, or eye disease, and in 13 out of 41 whose disease was either inactive or well controlled by drugs and who had no worsening of symptoms.
If those with the disease well controlled by drugs were included in the 'active' group, klebsiella was carried by 14 out of 63 with 'active' and 10 out of 26 with inactive disease. None of these differences is statistically significant. None of the 11 patients with inactive disease from whom klebsiella was isolated or initial culture developed worsening of pain in the following 2 months. One out of the 17 patients with inactive disease in whom klebsiella was not found developed worsening of pain in the following 2 months. 3,4,7 (x2), 11, 18,20,23,25,26,39,53 (x4), 55, 57, 58, 60, 71. Non-typable ( x 2) Serotypes found in RA 3 (x 2), 8,9, 10, 14, 18 (x 3), 19, 23, 27, 35, 38 (x 2), 47, 53 (x 3), 55, 59 Non-typable ( x 4).
Six out of 89 AS patients commented on past exacerbation of their symptoms after diarrhoea (3 culture-positive, 3 culture-negative) and 6 patients after upper respiratory tract infections (2 culturepositive, 4 culture-negative). Four AS patients had felt better during upper respiratory tract infections. Three out of 82 RA patients complained of worse pain after diarrhoea (1 culture-positive, 2 culture-negative) and 8 patients after upper respiratory tract infections (3 culture-positive, 5 culture-negative).
Twenty-two out of 24 klebsiella isolates from AS patients and 22 out of 26 from RA patients were serotypable. Serotypes were randomly distributed between patients with AS and RA ( In several respects our study differs from those previously described. The numbers were lower because we excluded many patients-recent inpatients, those with associated diseases, non-Caucasians, and first generation immigrants. We also completed the study in a limited time, with approximately equal numbers of AS and RA patients in each week, both measures being designed to minimise changes in isolation rate due to methodological variation or seasonal change. Klebsiella is known to be present in cold rather than hot foods (Casewell and Phillips, 1978b ). We did not exclude patients on the grounds of age over 40 years; there was no difference in klebsiella carriage rate in our patients aged under 40, nor were they more likely to suffer disease exacerbations if culture-positive.
The present study may differ in important microbiological respects: faeces from AS patients, RA patients, and controls were examined only once. There is little information on the stability of klebsiella carriage in the human faecal flora (Montgomerie et al., 1970, Casewell and Phillips, 1978a) . However, these reports, our limited studies in geriatric patients, and experience of other authors with Escherichia coli suggest that unusual frequency of sampling of active and inactive disease could distort the apparent frequency of klebsiella carriage if 1 positive out of a number of cultures is considered to imply positivity throughout a 3-month period. Hartley and her colleagues studied carriage of E. coli in 13 persons over a minimum period of 34 days (range 6-14 stools per individual) (Hartley et al., 1977) . Within this period 10 of the majority of coliform colonies from 127 stools were examined and identified. These 13 people experienced 74 serotypes of E. coli. Nine serotypes were present for more than 14 days continuously; 24 serotypes were isolated on a single occasion only; 10 serotypes were isolated more than once but never on 2 consecutive occasions. On only 33 
